Research Report University Hospital for clinical assessment M12-555

Abstract

A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa

Keywords

• Hidradenitis suppurativa
• adalimumab